We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Urea Breath Test Diagnoses Helicobacter pylori Infections

By HospiMedica staff writers
Posted on 23 May 2007
A urea breath test has been developed for both initial diagnosis and post-treatment monitoring of Helicobacter pylori infection in adults, an important pathogen in the upper gastrointestinal (GI) tract of humans.

The relationship between H pylori and chronic active gastritis, duodenal ulcer, and gastric ulcer is well documented. More...
The breath test is intended for use in adult patients. The performance characteristics for persons under the age of 18 have not been established for this test.

Produced by Meretek Diagnostics, Inc., (Lafayette, CO, USA), the test is called BreathTek UBT (urea breath test). The company exhibited the kit at the 2007 Digestive Disease Week conference, which was held May 20-23, 2007, in Washington DC (USA).

The test should be administrated by health care professionals under a physician's supervision. The test is simple, non-radioactive, and non-invasive. BreathTek UBT is 95% sensitive and specific, and is also used to confirm eradication four weeks following completion of treatment.

The test should not be used until four weeks or more after the end of treatment for the eradication of H pylori as earlier post-treatment assessment may give false-negative results.


Related Links:
Meretek Diagnostics

Gold Member
Blood Gas Analyzer
i-Check200
Radiology Monitor
MDNC-6121 Barco Nio Color 5.8MP
Medical Examination & Procedure Light
Vega 80
Tourniquet System
heidi– mein Tourniquet
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: New findings show that chemotherapy plus immunotherapy before surgery produced greater tumor destruction than immunotherapy alone in head and neck cancer patients (Image Credit: Adobe Stock)

Combination Therapy Before Surgery Drives Stronger Tumor Reduction in Head and Neck Cancer

Patients with head and neck cancer who are scheduled for surgery often face a waiting period with limited treatment, creating an opportunity to reduce viable tumor burden before the operation.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.